Return to homepagePandemic Pact

COVAC-1 and COVAC-2 RNA vaccine

  • Funded by UK Research and Innovation (UKRI)
  • Total publications:0 publications

Grant number: C19-IUC-173

Grant search

Key facts

  • Disease

    COVID-19

  • Funder

    UK Research and Innovation (UKRI)

  • Principal Investigator

    Sheena McCormack

  • Research Location

    United Kingdom

  • Lead Research Institution

    MRC Clinical Trials Unit at UCL

  • Research Priority Alignment

    N/A

  • Research Category

    Vaccines research, development and implementation

  • Research Subcategory

    Phase 1 clinical trial

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Clinical Trial, Phase I

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

To evaluate safety and efficacy of a candidate RNA vaccine against the spike1 glycoprotein that binds to the ACE2 receptor and facilitates entry compared to placebo. Phase 1 has started enrollment of healthy volunteers. http://www.isrctn.com/ISRCTN17072692